Articles

Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia

Department of Hematopathology
Department of Hematopathology
Department of Biostatistics
Department of Biostatistics
Department of Hematopathology
Department of Hematopathology
Department of Hematopathology
Department of Hematopathology
Department of Hematopathology
Department of Hematopathology
Department of Hematopathology
Department of Hematopathology
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Hematopathology
Department of Hematopathology
Department of Hematopathology
Vol. 104 No. 2 (2019): February, 2019 https://doi.org/10.3324/haematol.2018.191148